Evidence map›Paper›PMID 38421088›Full record

ArticleCNS neuroscience & therapeutics2024

Activation of testosterone-androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis-induced stroke rats.

Yu Feng, Zhihai Huang, Xiaohui Ma, Xuemei Zong, Celeste Yin-Chieh Wu, Reggie Hui-Chao Lee, Hung Wen Lin, Michael R Hamblin, Quanguang Zhang

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yu FengDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Zhihai HuangDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Xiaohui MaDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Xuemei ZongDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Celeste Yin-Chieh WuDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Reggie Hui-Chao LeeDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.ORCID 0000-0001-6099-8333
Hung Wen LinDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Michael R HamblinWellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Quanguang ZhangDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.ORCID 0000-0001-6499-7952
Louisiana State University in Shreveport · USHarvard University · US

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
Low Level Laser Therapy in Alzheimer's DiseaseRF1AG058603 · NIA · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ZHANG, QUANGUANG · 2018 to 2018
$1.9M
Synergistic Photodynamic Therapy for Catherer-Associated Urinary Tract InfectionsR21AI121700 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2016 to 2017
$462k
NIAID NIH HHS R01 AI050875NIAID NIH HHS R21 AI121700NIA NIH HHS RF1 AG058603NIH HHS R01AI050875NIH HHS R21AI121700NIH HHS RF1AG058603
6 · The paper itself

Abstract

rationaleNumerous epidemiological studies have reported a link between low testosterone levels and an increased risk of cerebrovascular disease in men. However, there is ongoing controversy surrounding testosterone replacement therapy due to potential side effects. PBMT has been demonstrated to improve cerebrovascular function and promote testosterone synthesis in peripheral tissues. Despite this, the molecular mechanisms that could connect PBMT with testosterone and vascular function in the brain of photothrombosis (PT)-induced stroke rats remain largely unknown.

methodsWe measured behavioral performance, cerebral blood flow (CBF), vascular permeability, and the expression of vascular-associated and apoptotic proteins in PT-induced stroke rats treated with flutamide and seven consecutive days of PBM treatment (350 mW, 808 nM, 2 min/day). To gain further insights into the mechanism of PBM on testosterone synthesis, we used testosterone synthesis inhibitors to study their effects on bEND.3 cells.

resultsWe showed that PT stroke caused a decrease in cerebrovascular testosterone concentration, which was significantly increased by 7-day PBMT (808 nm, 350 mW/cm

conclusionsOur study provides evidence that PBMT attenuates cerebrovascular injury and behavioral deficits associated with testosterone/AR following ischemic stroke. Our findings suggest that PBMT may be a promising alternative approach for managing cerebrovascular diseases.

Indexed as

Low-Level Light TherapyStrokeAndrogensAnimalsEndothelial CellsFlutamideHumansMaleMiceRatsReceptors, AndrogenTestosteroneAndrogensFlutamideReceptors, AndrogenTestosteronebEnd.3 cellsPBMTstroketestosteronevascular protection

Identifiers

PMID38421088
PMCPMC10851319
OpenAlexW4391652808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.